On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
ThursdayJul 28, 2016 1:39 pm

International Stem Cell Corp. (ISCO) Announces Successful Intracranial Cell Transplantation in Phase I Clinical Study of ISC-hpNSC

Before the opening bell, International Stem Cell Corp. (OTCQB: ISCO) announced that the first patient in its ongoing phase I clinical trial of human parthenogenetic neural stem cells (ISC-hpNSC) for the treatment of moderate to severe Parkinson’s disease has undergone a successful intracranial transplant of ISC-hpNSC at the Royal Melbourne Hospital in Australia. This milestone marks a major step toward the completion of the dose escalation safety and preliminary efficacy study, which will evaluate three different dose regimens of ISC-hpNSC in a total of 12 participants over the coming months. “This is a major step forward in our search for…

Continue Reading

ThursdayJul 28, 2016 1:36 pm

FRONTEO (FTEO) Granted Patent for Technology that Predicts Patient Falls in Healthcare Facilities

Recently, FRONTEO, Inc. (NASDAQ: FTEO) and FRONTEO, Inc. Healthcare (“FRONTEO Healthcare”) announced the reception of a patent approval from the Japan Patent Office for their AI-based technology (http://nnw.fm/ey2Xq). This new technology will be used in healthcare facilities in order to better predict patient falls. The AI-based technology analyzes the unstructured textual data from electronic medical and examination records to detect signs that a patient is going to fall. FRONTEO, Inc. is a leading technology and services company providing international litigation support and big-data services, among others. FRONTEO Healthcare is a FRONTEO subsidiary that analyses medical data and records to then…

Continue Reading

ThursdayJul 28, 2016 1:19 pm

Amgen (AMGN) and Union Chimique Belge send Romosozumab Biologics License Application to FDA

In a recent press release, Amgen (NASDAQ: AMGN) and Union Chimique Belge (UCB) disclosed the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for Romosozumab. Romosozumab is a monoclonal anti-sclerostin antibody for the treatment of osteoporosis in postmenopausal women, a group at increased risk of fracture. A BLA is similar to a New Drug Application (NDA). However, since Romosozumab is an antibody, it is classified as a biologic rather than a drug. Monoclonal antibodies are those made by identical immune cells that are all clones of a unique parent cell. Announcing the application…

Continue Reading

WednesdayJul 27, 2016 3:57 pm

Inventergy Global, Inc. (INVT) Secures $3 Million Private Placement

In a recent news release, Inventergy Global, Inc. (NASDAQ: INVT) announced its entry into a definitive agreement with institutional investors for the private placement of shares of its Series E convertible preferred stock and warrants to purchase shares of common stock. Gross proceeds from this placement total $3 million. Of this, Inventergy plans to use $2.5 million to redeem roughly 70 percent of existing shares of Series C convertible preferred stock, with the remaining net proceeds serving as working capital. The Series E preferred stock to be issued as part of this placement will include a cash dividend of five…

Continue Reading

WednesdayJul 27, 2016 1:13 pm

Fuel Tech (FTEK) Awarded Multiple Air Pollution Control Contracts Valued at $2.3 Million

Fuel Tech, Inc. (NASDAQ: FTEK), an advanced engineering company involved in the development, commercialization, and application of innovative technologies, recently announced receiving various air pollution control (APC) contracts valued at approximately $2.3 million (http://nnw.fm/x74B4). The company, which enables its customers to produce both energy and processed materials in a more environmentally-friendly way, is set to start the new contracts in China, the Middle East, and the U.S. The projects in question are already underway and should be completed by mid-2017. Vincent J. Arnone, president and chief executive officer, had this to say: “We are excited to announce this SNCR order…

Continue Reading

TuesdayJul 26, 2016 3:08 pm

Sunworks (SUNW) Rapid Rack Division Named Favorite Racking System by Boviet Solar USA

Boviet Solar USA has officially announced Sunworks, Inc. (NASDAQ: SUNW) as its preferred racking solution for its solar panels. Sunworks is one of the leading providers of solar power solutions and equipment. With this in mind, the companies plan to collaborate on two upcoming Boviet projects in North Carolina. Eric Ma, president and managing director of Boviet Solar USA, described the Rapid Rack mounting system as the perfect solution to complement Boviet’s high-efficiency solar modules. Boviet Solar USA is one of the world leaders in advanced materials and ranks among the best manufacturers working with advanced PERC technology. Eric Ma…

Continue Reading

TuesdayJul 26, 2016 2:56 pm

eXp World Holdings, Inc. (EXPI) Adds Two New Members to Board of Directors

Earlier today, eXp World Holdings, Inc. (OTCQB: EXPI) announced the addition of Rick Miller and Randall Miles to its Board of Directors. Glenn Sanford, chief executive officer of EXPI, described the move as a “significant point for the Company and for its shareholders.” In addition to bringing years of experience at the highest levels of leadership and deep and diverse expertise spanning a variety of industries, Miller and Miles offer “greater independence to [the Board’s] composition as the Company progresses, both within the public financial markets and as a rapidly-growing organization,” according to Sanford. Rick Miller brings more than 25…

Continue Reading

MondayJul 25, 2016 2:02 pm

Momentous Entertainment Group, Inc. (MMEG) Announces Content Distribution Agreement with Poolworks Germany LTD

Before the opening bell, Momentous Entertainment Group, Inc. (OTC: MMEG) announced entry into a binding agreement with Poolworks Germany LTD, one of the largest social media firms in Germany, through which Momentous will provide Hollywood quality film and television content to an audience of more than 10 million subscribers. According to the terms of this agreement, Momentous will deliver its content to Poolworks’ leading social media platforms, StudiVZ and MeinVZ. From there, the content will be deployed to audiences through the use of a full over-the-top (OTT) streaming solution. The company’s programming will be available to the platforms’ users on…

Continue Reading

MondayJul 25, 2016 1:59 pm

Broadwind Energy, Inc. (BWEN) Secures $15 Million in New Wind Turbine Tower Orders

Broadwind Energy, Inc. (NASDAQ: BWEN) recently announced the reception of $15 million in new wind turbine tower orders. The contract is expected to be completed in the fourth quarter of this year. The company plans to produce these towers in its Manitowoc, Wisconsin, facility ahead of scheduled delivery in 2017. “We are pleased to be awarded this order for 2017 production,” Stephanie Kushner, president and chief executive officer of Broadwind, stated in a news release. “There is a lot of positive momentum occurring within our Towers business as we continue to benefit from the strong wind market dynamics in the…

Continue Reading

FridayJul 22, 2016 12:47 pm

Bovie Medical (BVX) says Hologic to Market J-Plasma in the U.S.

On July 21, 2016, Bovie Medical (NYSEMKT: BVX) announced (http://nnw.fm/WWw3V) the signing of a sales channel partnership agreement, which takes immediate effect, with Hologic (NASDAQ: HOLX). In announcing the agreement, Bovie Medical’s CEO, Robert L. Gershon, affirmed: “We are proud to partner with a Company of Hologic’s caliber. This agreement is an important milestone in our strategy to scale J-Plasma® through select sales channel partnerships across multiple specialties that represent large addressable market opportunities.” J-Plasma® will initially be added to Hologic’s world-class portfolio of healthcare solutions in gynecological and gynecological/oncological surgery in three U.S. regions. The agreement, which is for…

Continue Reading

Contact us: 212.418.1217